16-Dehydropregenolone Acetate | CAS:979-02-2

We serve 16-Dehydropregenolone Acetate CAS:979-02-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
16-Dehydropregenolone Acetate

CAS No: 979-02-2
Product Name: 16-Dehydropregenolone Acetate
Other Name:
16-Dehydropregenolone Acetate
(3β)-20-Oxopregna-5,16-dien-3-yl acetate
3β-Acetyloxy-pregna-5,16-dien-20-one
3β-Acetoxypregna-5,16-dien-20-one
5,16-Pregnadiene-3β-ol-20-one acetate
3β-Acetoxy-5,16-pregnadien-20-one
Acetate pregnancy dehydropregnenolone
(3S,8R,9S,10R,13S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
3-Acetyloxypregna-5,16-dien-20-one
3-Hydroxypregna-5,16-dien-20-one3-acetate
 
Density: 1.1±0.1 g/cm3
Boiling Point: 464.4±45.0 °C at 760 mmHg
Melting Point: 170-178ºC
Molecular Formula: C23H32O3
Molecular Weight: 356.498
Flash Point: 200.1±28.8 °C
Exact Mass: 356.235138
PSA: 43.37000
LogP: 5.14
Vapour Pressure: 0.0±1.1 mmHg at 25°C
Index of Refraction: 1.547
 
Specification
Appearance: White Crystalline powder
Assay: ≥98.0%
Loss on drying:≤0.5%
Related substances:≤0.1%
 
Application
1. As an intermediate of steroid hormone drugs, it can produce corticosteroids, protein-curing hormones, androgens and luteal hormones.
2. Intermediates of cortisone acetate, hydrocortisone and progesterone hexanoate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 16-Dehydropregenolone Acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Hydroxypregna-5,16-dien-20-one3-acetate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Acetyloxypregna-5,16-dien-20-one Use and application,3β-Acetyloxy-pregna-5,16-dien-20-one technical grade,usp/ep/jp grade.


Related News: In recent years, the government has heavily promoted TCM, as part of efforts by Xi to bolster the country’s health sector and fill the gaps in national insurance schemes.7-(3-Chloropropoxy)-6-methoxy-4-oxo-1,4-dihydro-3-quinolinecarbon itrile manufacturer The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.(Z)-methyl 2-((tert-butoxycarbonyl)amino)-3-(4-carbamoyl-2,6-dimethylphenyl)acrylate supplier We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.1,2,3,4,5-Pentafluorobenzene vendor In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”